Characteristic | Apatinib (n = 25) |
---|---|
Sex, n (%) | |
Male | 17 (68) |
Female | 8 (32) |
Age, years | |
Median (range) | 53 (26–70) |
≥60, n (%) | 7 (28) |
<60, n (%) | 18 (72) |
Smoking history, n (%) | |
Yes | 10 (40) |
No | 15 (60) |
Histology, n (%) | |
Thymic carcinoma | 15 (60) |
Thymoma | 10 (40) |
Masaoka’s stage, n (%) | |
IVa | 4 (16) |
IVb | 21 (84) |
Number of prior therapy lines | |
1, n (%) | 12 (48) |
≥2, n (%) | 13 (52) |
ECOG performance status, n (%) | |
0 | 4 (16) |
1 | 21 (84) |
Number of metastatic lesions, n (%) | |
1 | 5 (20) |
≥2 | 20 (80) |